Pairing bariatric procedure with diabetes drug increases weight loss

(Digestive Disease Week) Combining minimally invasive endoscopic sleeve gastroplasty (ESG) with the diabetes drug semaglutide can provide additional significant weight loss for patients who are not candidates for invasive weight-loss surgery, according to research that was selected for presentation at Digestive Disease Week ® (DDW) 2021.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news